Literature DB >> 35035161

Recently Described Entity of Intracholecystic Papillary Neoplasm of Gallbladder with Coexisting Xanthogranulomatous Cholecystitis: an Unusual Association.

Monal Trisal1, Sabina Khan1, Musharraf Husain2, Nehal Ahmad1, Mohd Jaseem Hassan1, Sujata Jetley1.   

Abstract

Intracholecystic papillary neoplasm (ICPN) of the gallbladder is a relatively new concept and is suspected to share clinicopathologic features with intraductal papillary mucinous neoplasm (IPMN) of the pancreas and intraductal papillary neoplasm of the bile duct (IPNB). The literature on the clinicopathologic characteristics of preinvasive intraepithelial neoplasms of the gall bladder is fairly limited, partly owing to variability in its definition and terminology. We report an extremely rare case of coexistent xanthogranulomatous inflammation and intracholecystic tubulo-papillary neoplasm with low-grade dysplasia in a 48-year-old male patient. Although there are many case reports of simultaneous carcinoma gallbladder with xanthogranulomatous cholecystitis (XGC), however, the association of ICPN with XGC has not been previously described. To the best of our knowledge, this is the first case report of ICPN of gallbladder coexisting with xanthogranulomatous cholecystitis. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Gall bladder carcinoma; Intracholecystic papillary-tubular neoplasms; Xanthogranulomatous cholecystitis

Year:  2021        PMID: 35035161      PMCID: PMC8716777          DOI: 10.1007/s13193-021-01400-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  9 in total

Review 1.  Precancerous lesions of the biliary tree.

Authors:  Günter Klöppel; Volkan Adsay; Björn Konukiewitz; Jörg Kleeff; Anna Melissa Schlitter; Irene Esposito
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-04       Impact factor: 3.043

2.  Xanthogranulomatous cholecystitis: clinical, sonographic, and CT findings in 26 patients.

Authors:  J A Parra; O Acinas; J Bueno; A Güezmes; M A Fernández; M C Fariñas
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

3.  Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.

Authors:  Volkan Adsay; Kee-Taek Jang; Juan Carlos Roa; Nevra Dursun; Nobuyuki Ohike; Pelin Bagci; Olca Basturk; Sudeshna Bandyopadhyay; Jeanette D Cheng; Juan M Sarmiento; Oscar Tapia Escalona; Michael Goodman; So Yeon Kong; Paul Terry
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

4.  Intestinal metaplasia-dysplasia-carcinoma sequence of the gallbladder.

Authors:  H Yamagiwa; H Tomiyama
Journal:  Acta Pathol Jpn       Date:  1986-07

5.  Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.

Authors:  Sin Young Park; Sang Jae Roh; Yo Na Kim; Sung Zoo Kim; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

Review 6.  Xanthogranulomatous cholecystitis associated with carcinoma of the gallbladder.

Authors:  E W Benbow
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

7.  Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.

Authors:  Peng Yuan Zhuang; Ming Jie Zhu; Jian Dong Wang; Xue Ping Zhou; Zhi Wei Quan; Jun Shen
Journal:  J Dig Dis       Date:  2013-01       Impact factor: 2.325

8.  Intracholecystic papillary-tubular neoplasm of gallbladder: A 5-year retrospective pathological study.

Authors:  Prabir Hazarika; Manoj Kumar Sharma
Journal:  Indian J Pathol Microbiol       Date:  2018 Oct-Dec       Impact factor: 0.740

Review 9.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.